Objective The current study aims to assess Yemeni pharmacists' knowledge, attitude and practice of adverse drug reactions (ADRs) reporting systems and to determine barriers hindering them from reporting. Methods A cross-sectional descriptive study was conducted between August and October 2017. One hundred sixty-two pharmacists practicing in both community and hospital settings were recruited from five governorates using a convenient sampling technique. A validated self-administered questionnaire was used to collect data and to achieve the study objectives. Descriptive analysis was done using Statistical Package for Social Science version 20. Key findings Out of 260 questionnaires distributed, 162 pharmacists responded (Response rate of 62.3%). In terms of knowledge, 156 (96.3%) were not aware of the existence of ADRs reporting system in Yemen. The overall average knowledge score among pharmacists was 1.2 (SD = 1.2) out of 7. Concerning practice, about (140, 87.0%) of pharmacists disclosed that patients reported at least one ADRs annually. Insufficient clinical knowledge of pharmacist, unavailability of ADRs reporting form and unawareness of existence of the national ADRs reporting system were noticed to be the main barriers towards ADRs reporting. Conclusions Most of pharmacists were unaware of the ADRs reporting system in Yemen. However, advertising, education and intensive training are needed to improve awareness and to ensure an effective ADRs reporting process.
Pharmacists' knowledge and perceptions about pharmacovigilance and barriers towards adverse drug reactions reporting in Yemen 
Introduction
Patient safety is considered to be a major concern among healthcare systems around the world. [1, 2] Adverse drug reactions (ADRs) are one of the most common public health issues which are associated with increased morbidity, [3, 4] mortality, [5] hospitalization [6, 7] and costs raising of patients and society. [8] Based on the World Health Organization (WHO), ADRs are defined as 'a response to a medicine which is noxious and unintended which occurs at doses normally used in man for prophylaxis, diagnosis or therapy'. [9] Because it is difficult to discover all adverse effects of drugs prior to drug approval, post-marketing monitoring and spontaneous reporting of serious and less common ADRs is important to achieve a safe use of medications and to understand risks of drugs. [9] [10] [11] Pharmacovigilance concept is defined by WHO as the 'science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems'. [12] After the thalidomide disaster in the 1960s, most countries have established their national pharmacovigilance centres to regulate medication safety activity and thus ensure the rational and safe use of the medications. [13] Recently, in 2011, Yemen has established its national pharmacovigilance centre by Supreme Board of Drug and Medical Appliances (SBDMA) in the capital city 'Sana'a' as a starting point to report the ADRs. [14, 15] In many countries, pharmacists have a crucial role in identifying and reporting suspected ADRs since they face them in their daily patient care. [16] In developing countries, pharmacists have a prominent role in the healthcare system because they are the most accessible healthcare provider. [17] Despite that, evidence revealed that pharmacists have a little experience in reporting ADRs because of their insufficient knowledge about the pharmacovigilance concept. [2, 18, 19] Herein, the aim of conducting this study is to assess the knowledge, attitude and practice (KAP) of pharmacists in Yemen towards reporting ADRs and their activities in pharmacovigilance process.
Methods
Study design, setting and data collection This is a cross-sectional study that was carried out across five governorates of Yemen (Sana'a, Aden, Al-Hodeida, Ib, and Taiz) using a survey-based questionnaire. During the study period (August and October 2017), a self-administered questionnaires with mostly close-ended questions were distributed by study researchers to 260 pharmacists working at different working places using convenience sampling technique. The researchers explained the objective of the survey to all participants before their participation in the study; and after obtaining their agreement, pharmacists were handed a self-administered questionnaire to be filled. After that, the researchers came back later to collect the completed questionnaires and sent them for data entry process which was performed by a researcher who has not participated in the data collection.
Questionnaire
A validated KAP questionnaire was used as a tool for data collection. [19] This questionnaire consisted of four sections. The first one included pharmacists' demographic data, the second section assessed pharmacists' knowledge about pharmacovigilance. The third part included questions to assess pharmacists practice in reporting ADRs. The final part included questions to assess pharmacists' attitude towards ADRs reporting.
Scoring system
Pharmacists' knowledge about pharmacovigilance included seven questions. Pharmacists were asked two open-ended questions to define the concepts of pharmacovigilance and ADR and the answers were assessed based on the WHO definitions. Pharmacists' responses were classified either as correct or incorrect. For each correct answer, pharmacists awarded one point and a total score out of seven was calculated for each pharmacist.
Ethical consideration
The study was approved by the ethical committee/scientific research centre at Yemen University (Reference number: ERC/2017/101). The study was conducted following the ethical standards outlined in the World Medical Association Declaration of Helsinki guideline. [20] Participant's confidentiality was preserved using anonymous data collection form. Due to the anonymity of the study protocol, only verbal informed consents were obtained from all pharmacists before the interview.
Statistical analysis
The statistical analysis was performed using the Statistical Package for Social Science (SPSS) version 20.0 (IBM Corporation, Armonk, NY, USA). The descriptive statistics was done to calculate the mean and standard deviation (SD) for the continuous variables and to measure the frequency and percentages for the qualitative variables.
Results
Out of 260 distributed questionnaires, 162 (62.3%) pharmacists responded, in whom 125 (77.2%) were community pharmacists and 37 (22.8%) were hospital pharmacists. Of the respondents, 118 (72.8%) were men. The mean AE SD for age was 28.36 AE 2.90 while for working experience was 4.52 (SD = 4.07) ( Table 1) .
In terms of knowledge, the overall average knowledge score among pharmacists was 1.2 (SD = 1.2) out of 7. Although the majority of pharmacists (n = 114, 70.4%) had ever heard about the term of pharmacovigilance, but only 31 (19.1%) pharmacists could actually or conceptually define pharmacovigilance correctly. On the other hand, 70 (43.0%) pharmacists could mention the correct answer for the ADR. Very few (n = 6, 3.7%) pharmacists knew of the existence of pharmacovigilance centre in Yemen. Additionally, the vast majority (n = 147, 90.7%) claimed that did not know where they can get the ADR reporting form (Table 2) .
Concerning the practice of ADRs reporting, the majority of pharmacists (n = 140, 87.0%) had disclosed that patients 1 (0.6) reported to them at least one ADR annually. Most of the respondents preferred to deal with the severe ADRs by verifying if the ADR was known (n = 57, 35.2%) or asking the patient to contact the doctor (n = 52, 32.1%), while very few of them (n = 9, 5.2%) tend to report the sever ADRs directly. Regarding reporting ADRs, 38.3% (n = 62) of pharmacists admitted that they have ever reported any ADR during their pharmacy practice. Pharmacists were also asked about their preference for the reporting method of any ADRs. Near to half of them (n = 69, 43.4%) preferred informing the medical representative of the company during the routine visits while very few 4.4% (n = 7) tend to send the form of ADR reporting by e-mail (Table 3) .
Pharmacists were asked about factors encouraging and discouraging them from reporting ADRs. Of the respondents, the vast majority believed that they encouraged to report ADRs just when the reaction is classified as serious (n = 154, 95.6%) ( Table 4) . On the other hand, regarding challenges for reporting ADRs, the majority of pharmacists declared that the insufficient clinical knowledge represents the major barrier hindering them from reporting ADRs (n = 129, 82.2%) followed by unavailability of ADRs reporting form (n = 116, 74.9%) as well as unawareness about the existence of the national centre of ADRs reporting (n = 114, 73.1%). However, few of them considered ADRs reporting as the responsibility of doctors (n = 33, 20.9%) ( Table 5 ). Figure 1 illustrates the pharmacists' perception about the importance of ADRs reporting in which the highest percentage 98.1% (159) of pharmacists believed that enabling the safe drug to be identified is considered to be the main purpose forADRs reporting.
Pharmacists were also asked about their believes about whom is the responsibility for reporting ADRs. Majority of them claimed that the ADRs reporting is a responsibility of pharmacists (n = 143, 88.3%) followed by doctors (n = 140, 86.4%) as well as the drug companies (n = 101, 62.1%) (Figure 2 ).
Discussion
Issue of under-reporting of ADRs among healthcare professional was explored by several studies from other nations. [21] [22] [23] [24] [25] [26] [27] [28] [29] In Yemen, to the best of our knowledge, this is the first study conducted among pharmacists practicing in both community and hospital settings from five governorates which aimed at evaluating the knowledge, attitude and practice of both community and hospital pharmacists with regard to pharmacovigilance and ADRs reporting, in addition to determine the barriers towards reporting ARDs. This issue is critical to ensure an effective pharmacovigilance activity because knowledge of pharmacist will reflect the efficiency of ADRs reporting and thus affect the consequences resulted from under-reporting of ADRs. Overall, the vast majority of pharmacists (96.3%) were unaware of the presence of ADR reporting centre in Yemen, which is consistent with the results reported for Oman, Kuwait and Saudi Arabia. [22, 30, 31] Also, the majority (n = 147, 90.7%) of pharmacists disclosed that they did not know where they can get the ADRs reporting form. The main reason for these findings might be lack of activities such as workshops and regular conferences which should be carried out by the regulatory authorities and absence of regulations' fulfillment in both hospital and community pharmacy practice. Furthermore, the pharmacy profession in Yemen is considered to be a business oriented. These findings emphasize the urgent necessity to an extensive education to the pharmacists about pharmacovigilance and the importance of reporting system to ensure a medication safety to the Yemeni population. Such educational workshops have proved to be effective in increasing awareness and perception towards the process. [32] Concerning practice and attitude, the majority of respondents considered the reporting of the ADRs is a natural duty of the pharmacists as well as all health care professional, but the higher percentage was for the pharmacists. This finding was similar to results of previous studies conducted in Arabic countries. [2, 19, 31] In our study, most of the pharmacists stated that patients reported to them at least one ADR annually. Near to half (43.4%) of pharmacists reported that they tend to inform the medical representative of the companies during the routine visits to report ADRs. This is in contrast to a previous study conducted in Kuwait in which the pharmacists were preferred email or web-based reporting ADRs. [31] This might be due to lack of effective communication tools between pharmacists and the regulatory authorities of ADRs reporting system in Yemen. To enable safe drugs to be identified.
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In terms of barriers, the main reasons hindering pharmacists from reporting ADRs were insufficient clinical knowledge of pharmacist, unavailability of ADRs reporting form, unawareness about the existence of the national canter of ADR reporting system, insufficient data from the patient and not knowing how to report. All these findings were in agreement with results of a study conducted among pharmacists in Jordan, [19] in addition to the logistical barriers reported by Bawazir. [33] Also, a previous study revealed that the problem of insufficient knowledge was evident at the level of pharmacy students where this topic was not covered in Jordanian pharmacy collage curricula. [34] Uncertain association and too trivial ADR were seemed in our study as barriers preventing pharmacists from reporting. [21, 27] Moreover, some of the pharmacists still see the reporting of ADRs is a responsibility of physicians. [21, 24] Some of these barriers can be managed by proper advertising campaigns for the reporting program, and improving approaches to the ways that all pharmacists be able to communicate the information related to ADRs. Other barriers may be resolved through correspondence an intensive workshops and post-graduation mandatory training courses to improve the process of ADRs reporting in Yemen.
Despite those barriers, pharmacists disclosed that they encouraged to report ADR if the nature of ARD was serious, unusual and if the ADR that not reported before as well, which is consistent with the results of a study conducted among both hospital and community pharmacists in Jordan. [19] Based on the current finding mentioned, intensive workshops, education and training courses for pharmacists are recommended to increase the awareness about pharmacovigilance and importance of the ADRs reporting and thus guarantee an effective pharmacovigilance activity, which might reduce the underreporting issue and fulfill safe medicines to the Yemeni population.
The finding of the study should be interpreted with the main limitations in mind that the findings were based on pharmacists' self-rated assessment of their own knowledge, practice and attitude, which may have introduced overestimation to the results. The main strengthen point within this study is the recruitment of pharmacists from five governorates of Yemen (Sana'a, Aden, Al-Hodeida, Ib, and Taiz), which may enhance the generalizability of the results.
Conclusions
Most of pharmacists were obviously noticed to be unaware of the ARDs reporting system in Yemen. Insufficient clinical knowledge of pharmacist, unavailability of ARD reporting form, and unawareness of existence of the national pharmacovigilance centre were noticed to be the main barriers towards reporting. Advertising campaigns, electronic reporting, regulations' enforcement and postgraduation mandatory training courses are recommended to improve the awareness and decrease the barriers and thus guarantee an effective pharmacovigilance activity.
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